These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29667415)

  • 1. Rectal diclofenac does not prevent post-ERCP pancreatitis in consecutive high-risk and low-risk patients.
    Del Olmo Martínez L; Velayos Jiménez B; Almaraz Gómez A
    Rev Esp Enferm Dig; 2018 Aug; 110(8):505-509. PubMed ID: 29667415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
    Dumonceau JM; Andriulli A; Elmunzer BJ; Mariani A; Meister T; Deviere J; Marek T; Baron TH; Hassan C; Testoni PA; Kapral C;
    Endoscopy; 2014 Sep; 46(9):799-815. PubMed ID: 25148137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diclofenac Does Not Reduce the Risk of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Low-Risk Units.
    Rainio M; Lindström O; Udd M; Louhimo J; Kylänpää L
    J Gastrointest Surg; 2017 Aug; 21(8):1270-1277. PubMed ID: 28374181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effectiveness of the Rectal Administration of Low-dose Diclofenac for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Okuno M; Shiroko J; Taguchi D; Yamaguchi K; Takada J; Imai S; Sato H; Thanabashi S
    Intern Med; 2018 Aug; 57(16):2289-2294. PubMed ID: 29607957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydration with Lactated Ringer's solution combined with rectal diclofenac in the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography.
    Del Olmo Martínez ML; Velayos Jiménez B; Almaraz-Gómez A
    Gastroenterol Hepatol; 2021 Jan; 44(1):20-26. PubMed ID: 32674877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose rectal diclofenac does not prevent post-ERCP pancreatitis in low- or high-risk patients.
    Katoh T; Kawashima K; Fukuba N; Masuda S; Kobatake H; Masaki K; Araki Y; Kawano K; Nishi K; Takenaka M; Ishihara S; Kinoshita Y
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1247-1253. PubMed ID: 31788849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Lyu Y; Cheng Y; Wang B; Xu Y; Du W
    BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diclofenac is associated with a reduced incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis: results from a Danish cohort study.
    Leerhøy B; Nordholm-Carstensen A; Novovic S; Hansen MB; Jørgensen LN
    Pancreas; 2014 Nov; 43(8):1286-90. PubMed ID: 25003219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a cost-effectiveness analysis.
    Nicolás-Pérez D; Castilla-Rodríguez I; Gimeno-García AZ; Romero-García R; Núñez-Díaz V; Quintero E
    Pancreas; 2015 Mar; 44(2):204-10. PubMed ID: 25406954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.
    Levenick JM; Gordon SR; Fadden LL; Levy LC; Rockacy MJ; Hyder SM; Lacy BE; Bensen SP; Parr DD; Gardner TB
    Gastroenterology; 2016 Apr; 150(4):911-7; quiz e19. PubMed ID: 26775631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.
    Hauser G; Blažević I; Salkić N; Poropat G; Giljača V; Bulić Z; Štimac D
    Surg Endosc; 2017 Feb; 31(2):602-610. PubMed ID: 27317032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal Diclofenac administration for prevention of post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) acute pancreatitis. Randomized prospective study.
    Geraci G; Palumbo VD; D'Orazio B; Maffongelli A; Fazzotta S; Lo Monte AI
    Clin Ter; 2019; 170(5):e332-e336. PubMed ID: 31612188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diclofenac does not reduce the risk of acute pancreatitis in patients with primary sclerosing cholangitis after endoscopic retrograde cholangiography.
    Koskensalo V; Tenca A; Udd M; Lindström O; Rainio M; Jokelainen K; Kylänpää L; Färkkilä M
    United European Gastroenterol J; 2020 May; 8(4):462-471. PubMed ID: 32213036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
    Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
    BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Rectal Diclofenac Prevent Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis?
    Lua GW; Muthukaruppan R; Menon J
    Dig Dis Sci; 2015 Oct; 60(10):3118-23. PubMed ID: 25757446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 25 mg versus 50 mg dose of rectal diclofenac for prevention of post-ERCP pancreatitis in Japanese patients: a retrospective study.
    Yoshihara T; Horimoto M; Kitamura T; Osugi N; Ikezoe T; Kotani K; Sanada T; Higashi C; Yamaguchi D; Ota M; Mizuno T; Gotoh Y; Okuda Y; Suzuki K
    BMJ Open; 2015 Mar; 5(3):e006950. PubMed ID: 25795692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Sethi S; Sethi N; Wadhwa V; Garud S; Brown A
    Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of strategies for preventing post-ERCP pancreatitis after early precut sphincterotomy for biliary access.
    Ang TL; Kwek AB; Song M; Li JW; Thurairajah PH
    J Dig Dis; 2016 Oct; 17(10):692-696. PubMed ID: 27556283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
    Sperna Weiland CJ; Smeets XJNM; Kievit W; Verdonk RC; Poen AC; Bhalla A; Venneman NG; Witteman BJM; da Costa DW; van Eijck BC; Schwartz MP; Römkens TEH; Vrolijk JM; Hadithi M; Voorburg AMCJ; Baak LC; Thijs WJ; van Wanrooij RL; Tan ACITL; Seerden TCJ; Keulemans YCA; de Wijkerslooth TR; van de Vrie W; van der Schaar P; van Dijk SM; Hallensleben NDL; Sperna Weiland RL; Timmerhuis HC; Umans DS; van Hooft JE; van Goor H; van Santvoort HC; Besselink MG; Bruno MJ; Fockens P; Drenth JPH; van Geenen EJM;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):350-358. PubMed ID: 33740415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study.
    Lee TY; Choi JS; Oh HC; Song TJ; Do JH; Cheon YK
    Korean J Intern Med; 2015 Sep; 30(5):602-9. PubMed ID: 26354054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.